Figure 3.

Roles of LILRBs in hematological malignancies. (A-E) The schematic diagrams illustrate the functional roles of LILRBs in hematologic malignancies, depicting their interactions with specific ligands, activation of downstream signaling pathways, and subsequent modulation of tumor cell proliferation, migration, and T-cell function across distinct disease contexts: (A) acute myeloid leukemia (AML), (B) multiple myeloma (MM), (C) chronic lymphocytic leukemia (CLL), (D) acute T-cell leukemia (ATL), and (E) cutaneous T-cell lymphoma (CTCL).